## Abstract ## BACKGROUND Hospitalists, defined as hospitalβbased physicians who take responsibility for managing the medical needs of inpatients, represent a significant trend in physician specialization. However, only limited anecdotal data quantifying the status of hospital medicine groups arou
Erythrocytic glutathione reductase deficiency in a hospital population in the united states
β Scribed by Dr. Henri Frischer
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 452 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
In the USA, erythrocytic glutathione reductase (GSSGβR) deficiency is significantly more common, and can be considerably more pronounced in hospitalized patients (118/3198) than in outpatients (37/1639) or in apparently healthy persons (12/849). Retrospective analysis of illnesses found in 118 inpatients with erythrocytic GSSGβR deficiency revealed a striking and previously unsuspected association of the enzyme deficiency with a variety of chemotherapeutically treated hematological or nonhematological malignancies (51/118 patients, 43.2%, or 51/170 diagnoses, 30.0%). The prevalence of erythrocytic GSSGβR deficiency also increased in malnutrition, liver disease, and sepsis. Drugs of the nitrosourea class, particularly BCNU [1, 3βbis(2βchloroethyl)β1βnitrosourea] are causally implicated in the association of GSSGβR deficiency with malignancies. Severe or complete GSSGβR deficiency may handicap host response to infections.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Breast carcinoma survival rates were found to be higher in the U.S. than in Europe. ## METHODS Multiple regression analysis of breast carcinoma survival rates among women diagnosed between 1990 and 1992 was performed using clinical data from populationβbased case series
In recent years, most health care markets in the United States (US) have experienced rapid penetration by health maintenance organizations (HMOs) and preferred provider organizations (PPOs). During this same period, the US has also experienced slowing health care costs. Using a national database, we